Estrogen adversely affects the prognosis of patients with lung adenocarcinoma

Divergent regulation of theOsteopontinpromoter by the estrogen receptor-related receptors is isoform- and cell context dependent

(2013) R.A. Zirngibl et al.   JOURNAL OF CELLULAR BIOCHEMISTRY

Antiestrogen Fulvestrant Enhances the Antiproliferative Effects of Epidermal Growth Factor Receptor Inhibitors in Human Non–Small-Cell Lung Cancer

(2013) Edward B. Garon et al.   Journal of Thoracic Oncology

Expression levels of estrogen receptor beta in conjunction with aromatase predict survival in non-small cell lung cancer

(2011) Vei Mah et al.   LUNG CANCER

Reduction of Elevated Plasma Osteopontin Levels With Resection of Non–Small-Cell Lung Cancer

(2010) Justin D. Blasberg et al.   JOURNAL OF CLINICAL ONCOLOGY

Lung Cancer Among Postmenopausal Women Treated With Estrogen Alone in the Women's Health Initiative Randomized Trial

(2010) Rowan T. Chlebowski et al.   JNCI-Journal of the National Cancer Institute

Serum Osteopontin Levels are Highly Prognostic for Survival in Advanced Non-small Cell Lung Cancer: Results from JMTO LC 0004

(2010) Shun-Ichi Isa et al.   Journal of Thoracic Oncology

Ligand-Independent Antiapoptotic Function of Estrogen Receptor-β in Lung Cancer Cells

(2010) GuangFeng Zhang et al.   MOLECULAR ENDOCRINOLOGY

Targeting Aromatase and Estrogen Signaling in Human Non-Small Cell Lung Cancer

(2009) Diana C. Márquez-Garbán et al.   Annals of the New York Academy of Sciences

Hormone replacement therapy and survival in lung cancer in postmenopausal women in a rural population

(2009) Bin Huang et al.   CANCER

Immunohistochemical Expression of Estrogen and Progesterone Receptors Identifies a Subset of NSCLCs and Correlates with EGFR Mutation

(2009) M. G. Raso et al.   CLINICAL CANCER RESEARCH

Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a post-hoc analysis of a randomised controlled trial

(2009) Rowan T Chlebowski et al.   LANCET

Sex-associated differences in non-small cell lung cancer in the new era: Is gender an independent prognostic factor?

(2009) Li-Han Hsu et al.   LUNG CANCER

Gefitinib or Carboplatin–Paclitaxel in Pulmonary Adenocarcinoma

(2009) Tony S. Mok et al.   NEW ENGLAND JOURNAL OF MEDICINE

Intratumoral Estrogens and Estrogen Receptors in Human Non-Small Cell Lung Carcinoma

(2008) H. Niikawa et al.   CLINICAL CANCER RESEARCH

Lower Osteopontin Plasma Levels Are Associated With Superior Outcomes in Advanced Non–Small-Cell Lung Cancer Patients Receiving Platinum-Based Chemotherapy: SWOG Study S0003

(2008) Philip C. Mack et al.   JOURNAL OF CLINICAL ONCOLOGY

Association Between Estrogen Receptor-β Expression and Epidermal Growth Factor Receptor Mutation in the Postoperative Prognosis of Adenocarcinoma of the Lung

(2008) Naohiro Nose et al.   JOURNAL OF CLINICAL ONCOLOGY

Estrogen Receptor (ER) and Epidermal Growth Factor Receptor (EGFR) as Targets for Dual Lung Cancer Therapy: Not Just a Case?

(2008) Monica Giovannini et al.   Journal of Thoracic Oncology

Osteopontin is involved in the formation of malignant pleural effusion in lung cancer

(2008) Ri Cui et al.   LUNG CANCER

Estrogen Receptor β Functions through Nongenomic Mechanisms in Lung Cancer Cells

(2008) GuangFeng Zhang et al.   MOLECULAR ENDOCRINOLOGY